We observe that patients with PRAD tumours have higher expression of FOXA1 and HOXB13 compared to the normal prostate tissue and poor survival is associated with high FOXA1 expression (Supplementary Fig. 10). The gene discussed is HOXB13; the disease is prostate adenocarcinoma.